[go: up one dir, main page]

AU3305699A - Prostate-specific membrane antigens and methods of making and using - Google Patents

Prostate-specific membrane antigens and methods of making and using

Info

Publication number
AU3305699A
AU3305699A AU33056/99A AU3305699A AU3305699A AU 3305699 A AU3305699 A AU 3305699A AU 33056/99 A AU33056/99 A AU 33056/99A AU 3305699 A AU3305699 A AU 3305699A AU 3305699 A AU3305699 A AU 3305699A
Authority
AU
Australia
Prior art keywords
prostate
making
methods
specific membrane
membrane antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU33056/99A
Inventor
Lana S Grauer
Kristine Kuus-Reichel
Roger Sokoloff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beckman Coulter Inc
Original Assignee
Beckman Coulter Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beckman Coulter Inc filed Critical Beckman Coulter Inc
Publication of AU3305699A publication Critical patent/AU3305699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU33056/99A 1998-02-26 1999-02-22 Prostate-specific membrane antigens and methods of making and using Abandoned AU3305699A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3122098A 1998-02-26 1998-02-26
US09031220 1998-02-26
PCT/US1999/003810 WO1999043710A1 (en) 1998-02-26 1999-02-22 Prostate-specific membrane antigens and methods of making and using

Publications (1)

Publication Number Publication Date
AU3305699A true AU3305699A (en) 1999-09-15

Family

ID=21858247

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33056/99A Abandoned AU3305699A (en) 1998-02-26 1999-02-22 Prostate-specific membrane antigens and methods of making and using

Country Status (2)

Country Link
AU (1) AU3305699A (en)
WO (1) WO1999043710A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136311A (en) 1996-05-06 2000-10-24 Cornell Research Foundation, Inc. Treatment and diagnosis of cancer
US6107090A (en) 1996-05-06 2000-08-22 Cornell Research Foundation, Inc. Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains
WO2000050457A1 (en) * 1999-02-22 2000-08-31 Beckman Coulter, Inc. Prostate-specific membrane antigens and methods of making and using
IL159422A0 (en) 2001-09-20 2004-06-01 Cornell Res Foundation Inc Methods and compositions for treating or preventing skin disorders using binding agents specific for prostate-specific membrane antigen
WO2004063701A2 (en) 2003-01-10 2004-07-29 Millennium Pharmaceuticals, Inc. Methods of diagnosing and treating cancer
WO2004113571A2 (en) * 2003-06-26 2004-12-29 Exonhit Therapeutics Sa Prostate specific genes and the use thereof as targets for prostate cancer therapy and diagnosis
US20120141376A1 (en) * 2006-07-03 2012-06-07 Richard Einstein Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001526522A (en) * 1995-02-24 2001-12-18 スローン−ケタリング・インスティテュート・フォー・キャンサー・リサーチ Prostate specific membrane antigen and uses thereof
US5788963A (en) * 1995-07-31 1998-08-04 Pacific Northwest Cancer Foundation Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy
DE69735294T2 (en) * 1996-03-25 2006-09-21 Medarex Inc. SPECIFIC MONOCLONAL ANTIBODIES FOR THE EXTRACELLULAR DOMAIN OF PROTASTA SPECIFIC MEMBRANE ANTIGEN

Also Published As

Publication number Publication date
WO1999043710A1 (en) 1999-09-02

Similar Documents

Publication Publication Date Title
AU4597297A (en) Trans-sodium crocetinate, methods of making and methods of use thereof
AU7148498A (en) Surface modified porous membrane and process
AU1778199A (en) Oxygen sensing membranes and methods of making same
AU2002220070A1 (en) Cellulose ethers and method of preparing the same
AU2001259215A1 (en) Human anti-cd40 antibodies and methods of making and using same
AU2675999A (en) Membrane laminates and methods for their preparation
AU6059100A (en) Thermal and ph stable protein thickening agent and method of making the same
AU3068699A (en) Skin equivalent and methods of forming and using same
AU2389600A (en) Reservoir-and-filter system and method of use
AU6577898A (en) Structural element and method of making
AU8967998A (en) Antibiotic-ligand conjugates and methods of use thereof
AU3475300A (en) Skinned hollow fiber membrane and method of manufacture
AU3159499A (en) Antigen preparation and use
AU2762699A (en) Micro-fastening system and method of manufacture
AU5175798A (en) Membrane and methods of preparing and using same
AU2001260774A1 (en) Bio-support and preparing method of the same
AU6585498A (en) Novel uncoupling protein and methods of use
AU1115100A (en) Bone canal plug, method of making, and method of using
AU7332800A (en) Card construction, methods of making and using
AU6270799A (en) Firestarter and method of making same
AU9754898A (en) Sound muffling material and method of making thereof
AU3305699A (en) Prostate-specific membrane antigens and methods of making and using
AU1919699A (en) Micro-catheters and methods of their manufacture
AU1952497A (en) Novel antibody-cytokine fusion protein, and methods of making and using the same
AU2000239273A1 (en) Systems and methods of viral marketing

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase